FDA Clearance Tracker · K222625
Shield System
Last checked: Nov 20, 2026Latest source record: Sep 30, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Sep 30, 2022
Substantially Equivalent
Time to decision
30 days
Received Aug 31, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K222625
- Device name
- Shield System
- Applicant
- Radiaction , Ltd.
- Applicant location
- Tel Aviv, IL
- Received
- Aug 31, 2022
- Decided
- Sep 30, 2022
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.1650
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OWB. The earliest in FDA's data is K912448, decided Aug 28, 1991.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K222625
- The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Radiaction , Ltd.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260607 · Decided Jul 31, 2026 · 157 days after receipt
Device type: Interventional Fluoroscopic X-Ray System (OWB) · Radiology & Imaging
- Shield System510(k)
K212159 · Decided Mar 30, 2022 · 261 days after receipt
Device type: Interventional Fluoroscopic X-Ray System (OWB) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.